Recent advances in peptide-based nanovaccines for re-emerging and emerging infectious diseases
Peptide-based nanovaccines have emerged as promising strategies for combating re-emerging and emerging infectious diseases. They exhibit excellent immunogenicity and therapeutic potential. They have shown the ability to elicit robust immune responses, including activation of antigen-presenting cells...
Main Author: | Fredmoore Orosco |
---|---|
Format: | Article |
Language: | English |
Published: |
Bangladesh Society for Microbiology, Immunology, and Advanced Biotechnology
2024-04-01
|
Series: | Journal of Advanced Biotechnology and Experimental Therapeutics |
Subjects: | |
Online Access: | https://www.bsmiab.org/jabet/?mno=170681 |
Similar Items
-
Emerging peptide-based nanovaccines: From design synthesis to defense against cancer and infection
by: Feng Xu, et al.
Published: (2023-02-01) -
Nanovaccines against Viral Infectious Diseases
by: Wen Tzuen Heng, et al.
Published: (2022-11-01) -
Nanovaccines: A game changing approach in the fight against infectious diseases
by: Priyanka, et al.
Published: (2023-11-01) -
Efficacy and Immune Response Elicited by Gold Nanoparticle- Based Nanovaccines against Infectious Diseases
by: Anirban Sengupta, et al.
Published: (2022-03-01) -
Nanovaccines against Animal Pathogens: The Latest Findings
by: Carmen Teresa Celis-Giraldo, et al.
Published: (2021-09-01)